Generate a tailored SOP for Dr. Harry De Koning. Improve your application with a focused, well-structured draft.
Harry De Koning is a Professor at the University of Glasgow, specializing in the investigation of mechanisms of drug resistance in protozoan parasites, particularly African trypanosomes such as Trypanosoma brucei and Trypanosoma congolense. His research focuses on identifying new therapeutic strategies and lead compounds for treating diseases like African trypanosomiasis, also known as sleeping sickness. De Koning's work has led to significant findings regarding the transport proteins that enable parasites to take up essential nutrients and the mechanisms behind their resistance to various drug classes. Throughout his academic career, he has played an influential role in developing drug efficacy screening tools, collaborating extensively with pharmaceutical companies to facilitate the preclinical development of new anti-parasitic drugs. His contributions to the field are documented in numerous publications and research grants, reflecting his commitment to addressing the challenges of drug resistance and improving treatment outcomes in neglected diseases.
University of Glasgow • Glasgow, UK